Back to LCTX
Creative Planning LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
13
Latest value
$4.1M
Q3 2026
Peak value
$5.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $29K |
| Q3 2025 | $30K |
| Q3 2025 | $935K |
| Q4 2025 | $30K |
| Q4 2025 | $2.5M |
| Q1 2026 | $22K |
| Q1 2026 | $3M |
| Q2 2026 | $18K |
| Q2 2026 | $4K |
| Q2 2026 | $5.2M |
| Q3 2026 | $13K |
| Q3 2026 | $10K |
| Q3 2026 | $4.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.1M | 119.8K | — | — |
| Q3 2026 | $10K | 288 | — | — |
| Q3 2026 | $13K | 13.8K | — | — |
| Q2 2026 | $5.2M | 121.1K | — | — |
| Q2 2026 | $4K | 104 | — | — |
| Q2 2026 | $18K | 13.6K | — | — |
| Q1 2026 | $3M | 91.9K | — | — |
| Q1 2026 | $22K | 13.7K | — | — |
| Q4 2025 | $2.5M | 72.7K | — | — |
| Q4 2025 | $30K | 18.2K | — | — |
| Q3 2025 | $935K | 24.2K | — | — |
| Q3 2025 | $30K | 17.8K | — | — |
| Q3 2025 | $29K | 749 | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M